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Available online 20 August 2016RORα is a member of the nuclear receptor (NR) superfamily and analysis of the (global) RORα-deﬁcient mouse
model revealed this NR has a role in glycemic control and fat deposition. Therefore,we generated an adipose-spe-
ciﬁc RORα ‘gain of function’mousemodel under the control of the fatty acid binding protein 4 (FABP4) promoter
to elucidate the function of RORα in adipose tissue. The Tg-FABP4-RORα4mice demonstrated a shift in fat distri-
bution to non-adipose tissueswhen challengedwith a high fat diet (HFD). Speciﬁcally, we observed a subcutane-
ous lipodystrophy, accompanied by hepatomegaly (fatty liver/mild portal ﬁbrosis) and splenomegaly; in a
background of decreased weight gain and total body fat after HFD. Moreover, we observed signiﬁcantly higher
fasting blood glucose and impaired clearance of glucose in Tg-FABP4-RORα4 mice. Genome wide expression
and qPCR proﬁling analysis identiﬁed: (i) subcutaneous adipose speciﬁc decreases in the expression of genes in-
volved in fatty acid biosynthesis, lipid droplet expansion and glycemic control, and (ii) the ﬁbrosis pathway as the
most signiﬁcant pathway [including dysregulation of the collagen/extracellular matrix (ECM) pathways] in sub-
cutaneous adipose and liver. The pathology presented in the Tg-FABP4-RORα4 mice is reminiscent of human
metabolic disease (associated with aberrant ECM expression) highlighting the therapeutic potential of this NR.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Collagen1. Introduction
Obesity and diabetes are worldwide health burdens. The incidence
of obesity has doubled since 1980 with over 1.9 billion adults over-
weight in 2014, and globally N400 million people have type 2 diabetes.
Unfortunately, existing anti-obesity and anti-diabetic therapeutic dis-
play insufﬁcient efﬁcacy and adverse effects (Aguiree et al., 2013).
Therefore, there is a global need for novel therapeutic targets that regu-
late excessive adiposity and glycemic pathophysiology to treat those
populations challenged by adverse clinical outcomes. The nuclear hor-
mone receptor (NR) superfamily is comprised of hormone-dependent
transcription factors that translate physiological signals into gene regu-
lation to controlmetabolism in an organ-speciﬁcmanner. In the context
of metabolic disease, dysfunctional NR signaling results in dyslipidemia,
diabetes, and obesity. There are 48 NRs in humans, all implicated in dis-
ease, although not all with identiﬁed natural ligands; these NRs arezsimmons),
ript preparation.
. This is an open access article underdenoted as orphans. The NR, RORα, has been implicated in the regula-
tion of glucose and fat homeostasis, but has historically belonged to
the orphan class of NRs. However, interest in this speciﬁc receptor has
been stimulated by the rapid emergence of small molecule agonist
and inverse agonists (Smith and Muscat, 2006; Marciano et al., 2014).
Several studies suggest that RORα is a constitutively active receptor.
The constitutive recruitment of coactivators such as p300, glutamate re-
ceptor interacting protein 1 and steroid receptor coactivator 1
(reviewed in Fitzsimmons et al., 2012) by RORα in the absence of exog-
enous ligands supports a state of constitutive activation of RORα by a
common endogenous ligand (such as cholesterol metabolites and inter-
mediates) (reviewed in Fitzsimmons et al., 2012;Marciano et al., 2014).
For example, crystallographic and mass spectrometry studies showed
that the RORα-LBD is constitutively bound to endogenous ligands in-
cluding fatty acids, cholesterol metabolites and all trans retinoic acid
(reviewed in Marciano et al., 2014). Furthermore, the basal activity of
RORs is highlighted by the observation that natural inverse agonists
are exploited (for example ursolic acid) in RORγ reporter assays to iden-
tify agonists in reporter assays (Santori, 2015; Chang et al., 2016). Re-
cently, it was conﬁrmed that oxygenated sterols (natural LXR ligands
and agonists) function as native ligands, but as inverse agonists forthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Burris, 2014). Moreover, the crosstalk between the (oxysterol activated
NR) LXR and RORα/γ signaling pathways is underscored by our recent
study demonstrating decreased expression of the cholesterol 25-
hydroxylasemRNA (encodes the enzyme that produces the LXR agonist
25-hydroxycholesterol, 25-HC) and aberrant phagocytosis in the Rorα-
deﬁcient staggerer mice (sg/sg) (Tuong et al., 2013). New studies
(Tuong et al., 2016) implicate Rorα in regulating lipid storage inmacro-
phages in a process modulated by 25-HC levels.
The biological signiﬁcance of RORα in the regulation of important
metabolic pathways is underscored by studies on the (global) Rorα-
deﬁcient staggerer (sg/sg) mouse model. For example, analysis of the
global Rorα knockout model has revealed that Rorα regulates (i) adi-
posity (Lau et al., 2004, 2008), (ii) resistance to diet-induced obesity
and hepatic steatosis (Lau et al., 2008), (iii) thermogenesis and
browning/beiging of subcutaneous adipose tissue (SAT) (Lau et al.,
2015), (iv) insulin sensitivity and signaling (Lau et al., 2011), (v) inﬂam-
mation and phagocytosis (Tuong et al., 2013) and (vi) lipid droplet ho-
meostasis (Tuong et al., 2016).
Speciﬁcally, the Rorα-deﬁcient sg/sgmice display increased AKT sig-
naling in skeletal muscle (Lau et al., 2011), improved glucose tolerance
and insulin sensitivity. The lean phenotype in sg/sgmice is associated
with reduced serum triglyceride and cholesterol levels (Lau et al.,
2008, 2015; Kang et al., 2011; Mamontova et al., 1998). In addition, de-
creased adiposity is associated with an increased metabolic rate and
cold tolerance in Rorα-deﬁcient sg/sg mice. This phenotype involves
browning/beiging of SAT, increased uncoupling protein 1 (Ucp1) ex-
pression (mRNA and protein) and thermogenic gene expression (Lau
et al., 2015), and signiﬁcantly increased expression of the (cell-fate con-
trolling) histone-lysine N-methyltransferase 1 (Ehmt1), which stabi-
lizes the Prdm16 transcriptional complex. However, the signiﬁcance of
RORα in the regulation of adipose physiology remains unclear as it is
difﬁcult to dissect the contribution of this widely expressed receptor
from the complex interactions that give rise to the lean phenotype. Sev-
eral in vitro studies have suggested that RORα transcriptional activity
acts to suppress adipocyte differentiation. Embryonic ﬁbroblasts from
Rorα-deﬁcient sg/sgmice displayed enhanced differentiation into func-
tional adipocytes (Duez et al., 2009) and in 3T3-L1 cells RORα
constrained differentiation via increased expression during late adipo-
genesis (Okada et al., 2009). However, these authors also report a simi-
lar differentiation potentiality in pre-adipocytes sourced from
homozygous sg/sgmice as their heterozygous sg/+ counterparts. It is
evident that an in vivo investigation of RORα function - speciﬁcally in
adipose tissue (i.e. an organ/tissue speciﬁc mouse model) that can ac-
count for the developmental, metabolic and compartmental context, is
warranted. Therefore, we generated an adipose-speciﬁc RORα ‘gain of
function’ transgenic mouse model in order to further understand the
adipose-speciﬁc function of RORα in (i) lipid deposition, (ii) glucose tol-
erance and insulin sensitivity, (iii) obesity, and (iv) gene regulation. This
is highly signiﬁcant within the context of obesity as the capacity to ex-
pand the number of adipocyte cells to accommodate increased lipid
storage requirements is a key determinant of the degree of metabolic
dysfunction that accompanies increased adiposity.
Our studies indicate that (heterozygous, Tg-FABP4-RORα4 tg/+)
mice with adipose-speciﬁc RORα4 expression have impaired glucose
tolerance, decreased SAT, and hepatomegaly on a high fat diet, a pheno-
type often associated with obesity (Abdennour et al., 2014; Porter et al.,
2009; Tam et al., 2012). RNA-seq, targeted qPCR and canonical pathway
analysis suggests that adipose-speciﬁc RORα4 phenotype is associated
with differential regulation of the ﬁbrosis pathway in adipose and he-
patic tissue. For example, genes that encode the extracellular matrix
(ECM) collagen proteins are down-regulated in the SAT, but increased
in tg/+ hepatic tissue. This is in accord with the role of collagen produc-
tion in adipose development and physiology, as well as adipose plastic-
ity to suit metabolic demands and changes (Mariman andWang, 2010)
and ectopic/aberrant fat deposition (Aikio et al., 2014).2. Materials and Methods
2.1. Transgene Plasmid Generation
hRORα4 was ampliﬁed by PCR from pSG5-RZR (courtesy of Dr. OA
MacDougald, University of Michigan Medical School, USA (Becker-
Andre et al., 1993)) using a forward primer containing a SalI cut site:
AGCGTCGACCATGATGTATTTTGTGATCG and a reverse primer contain-
ing a NotI cut site: AATGCGGCCGCTTTACCCATCAATTTG. After SalI/NotI
double digestion, RZR was subcloned into SalI NotI double digested-
pCRII-FABP4 promoter vector (Longo et al., 2004) to generate FABP4-
RORα4 construct and veriﬁed by sequencing, prior to pronuclear
injection.
2.2. Animals and Tissue Collection
Generation of Tg-FABP4-RORα4 mice was performed by Transgenic
Animal Services Queensland. Pronuclear injection was performed in
C57BL/6/CBA mixed background mice. Founders were identiﬁed by
genotyping and FABP4-RORα4 positive transgenicmouse lineswere se-
lected for phenotypic analysis after N5 generations of backcrossing to
C57BL/6 background. 16 and 32week oldWT and FABP4-RORα4 trans-
genic littermates (Tg-FABP4-RORα4) were obtained from crossing het-
erozygous tg/+ Tg-FABP4-RORα4 transgenic breeders with C57BL/6
mice. Homozygous tg/tg Tg-FABP4-RORα4 mice were generated by
crossing heterozygous Tg-FABP4-RORα4males and females. All animals
were housed in the Queensland Bioscience Precinct Vivarium (UQ)with
a 12h light-dark cycle. The high fat diet used in this study is as described
in (Pearen et al., 2013). Animals were weaned at 4 weeks of age and
were fed the standard chow diet ad libitum (which contains 4.6% total
fat). In contrast, the high fat diet (SF03-002 Fat Modiﬁed Rodent Diet;
very high fat modiﬁcation of AIN93G) used in the study contains 36%
fat. Both diets were acquired from Specialty Feeds (Glen Forrest, West-
ern Australia). Experimental mice were weighed weekly. For tissue col-
lection,micewere fasted overnight in a new food-free holding cage and
subsequently euthanized. Tissues were collected and immediately
snap-frozen in liquid nitrogen and then stored at−80 °C. All aspects
of animal experimentationwere approved by The University of Queens-
land Animal Ethics Committee.
2.3. Intraperitoneal Glucose Tolerance Test and Insulin Tolerance Test
Blood glucose measurements were obtained from the tail vein of 6 h
fasted animals (14–16 weeks old or 22 week old mice on high fat diet)
following glucose or insulin challenge, using a blood glucose testing sys-
tem (Accu-chek Performa; Roche Diagnostics, Castle Hill, NSW, Austra-
lia) as described (Raichur et al., 2010). Glucose was administered to
each mouse at a dose of 2 g/kg and insulin was given at 1.0 U/kg.
2.4. Insulin Enzyme-linked Immunosorbent Assay (ELISA)
The ALPCOMouse ultrasensitive Insulin ELISA assay kit was used for
the quantitative determination of insulin plasma from 6 h or overnight
fasted mice. All procedures were performed according to
manufacturer's instructions.
2.5. Protein Extraction and Immunoblot Analysis
Protein extraction from adipose tissue was previously described
(Lau et al., 2015) with modiﬁcations. Inguinal white adipose tissues
were homogenized in 1 mM EDTA, 10 mM Tris, and 0.25 M sucrose
(pH 7.5) with 1xComplete protease inhibitor and 1xPHOS-STOP
(Roche Diagnostics, Mannheim, Germany). Infranatant and pellet
were separated from the top layer of fat cake after centrifugation. Deter-
gent was then added to a ﬁnal concentration of 1% Triton X-100, 1% NP-
40, and 0.1% SDS for the infranatant (cytosolic proteins) and pellet
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sheared eight timeswith an insulin syringe. The pelletwas shearedmul-
tiple times using P200 pipette tips and insulin syringe. Protein concen-
tration was measured with BCA reagent (Thermoscientiﬁc; Pierce,
Rockford, IL). Immunoblot analysis was performed as described previ-
ously except that the membranes were blocked in 5% skim milk and
probed with anti-RORα (ab60134 1:1000; Abcam), anti-AKT (#9272,
1:1000; Cell Signaling Technology, Danvers, MA), pAKT (ser473)
(#4058; 1:1000; Cell Signaling Technology), anti-TBP (sc-204; 1:1000,
Santa Cruz Biotechnology), or anti-α-tubulin (#2144, 1:1000; Cell Sig-
naling Technology).
2.6. Histology
Hematoxylin and eosin (H&E) staining was performed as described
(Lau et al., 2015), on parafﬁn-embedded tissues ﬁxed in 10% buffered
formalin (Sigma-Aldrich). Accustain® Trichrome Stains (Masson)
(Sigma-Aldrich)was used for staining collagenﬁbers in the liver accord-
ing to manufacturer's instructions. To assess macrophage inﬁltration
into adipose, immunohistochemistry was performed on deparafﬁnized
and re-hydrated sections. Enzymatic antigen retrieval was performed
using Proteinase K (20 μg/mL) in TE buffer (50 mM Tris, 1 mM EDTA,
pH 8.0) for 3 min at room temperature and rinsed with PBS. Macro-
phages were detected using a speciﬁc primary antibody for F4/80 (rat
anti-mouse, Abcam, ab6640) at 4 °C overnight. This was followed by
0.3% H2O2 treatment to reduce endogenous peroxidase activity, and
staining with species-matched horseradish peroxidase-conjugated sec-
ondary antibody (goat anti-rat antibody, Santa Cruz Biotechnology) at
room temperature for 1 h. All blocking steps were performed in 0.5%
BSA/PBS in the presence of 10% species-matched anti-sera. Sections
were then counterstained using Mayer's hematoxylin and mounted
using permanent mounting media. Sections were examined using an
Olympus BX-51 microscope with a DP-70 digital camera and DP con-
troller imaging software (Olympus Imaging Systems, PA, USA).
2.7. Blood Lipid Proﬁling and Measurement of Hepatic Triglyceride
Concentration
Measurements of total cholesterol, triglyceride, and non-esteriﬁed
fatty acid in heparinized plasma samples were analyzed by Clinical Pa-
thology Laboratory, School of Veterinary Science, The University of
Queensland (Gatton, Queensland, Australia).
2.8. Nuclear Magnetic Resonance (NMR) and Dual-energy X-ray Absorpti-
ometry (DEXA) Scans
NMR scanning was performed using a Bruker MiniSpec LF50
(Ettlingen, Germany). Total body percentage fat and percentage lean
mass values were extracted from the analysis. DEXA scanning was per-
formed on frozen liver tissues harvested from euthanized overnight-
fasted mice (32 weeks of age) and measured for lean mass and fat
mass using a PIXImus Densitometer (GE Lunar, Madison, WI).
2.9. Genotyping and Tissue Detection of Transgene Expression
Genotyping of mice from Tg-FABP4-RORα4 transgenic lines was
performed on toe/tail/ear puncture samples using QuickExtract™ DNA
Extraction Solution (Epicentre Biotechnologies, Madison, Wisconsin,
USA) according to manufacturer's protocol. For conﬁrmation of trans-
gene expression, RNA was extracted from tissues and cDNA synthesis
was performed as described (Pearen et al., 2009; Myers et al., 2009).
SYBR primerswere designed using Primer Express (Applied Biosystems,
Foster City, CA) for the following: mouse Rorα forward
CAATGCCACCTACTCCTGTCC and reverse GCCAGGCATTTCTGCAGC for
real-time endogenous expression and genotyping, and human RORα re-
verse CTACGGCAAGGCATTTCTGTAAT for real-time ectopic expressionand genotyping. The same forward primer was used for both real-time
endogenous and ectopic expression.
2.10. RNA Extraction and Puriﬁcation and cDNA Synthesis
Total RNA was extracted using TRI-Reagent (Sigma-Aldrich, St.
Louis, MO) and RNA puriﬁcation was performed using the RNeasy
mini kit (Qiagen, Clifton Hill, Victoria, Australia) according to the man-
ufacturers' instructions. Complementary DNA (cDNA) was synthesized
from 0.5–2 μg of puriﬁed total RNA using Superscript III Reverse Tran-
scriptase (Invitrogen) and random hexameric primers according to
the manufacturer's instructions.
2.11. qPCR Analysis
Relative expression of genes was determined using the Applied
Biosystems (ABI) ViiA™ 7 Real-Time PCR System (ABI, Singapore) as pre-
viously described (Lau et al., 2008; Tuong et al., 2013). Relative gene ex-
pression was analyzed by qPCR using either TaqMan Gene Expression
Assays (ABI, Foster City, CA), or TaqMan low-density arrays (TLDAs) as de-
scribed (Pearen et al., 2013), or primers designed for usewith SYBRmaster
mix. Assay on demand primers for TaqMan qPCR used are described (Lau
et al., 2004, 2015) and include the following: total RORα
(mouse + human; Mm00443103_m1), Tle3 (Mm00437097_m1),
Ehmt1 (Mm00553234_m1), Prdm16 (Mm00712556_m1),
Ucp1 (Mm01244861_m1), Cpt2 (Mm00487202_m1), Pnpla2
(Mm00503040_m1), Adrb3 (Mm00442669_m1), Ndufb5
(Mm00452592_m1), Dio2 (Mm00515664_m1), and Pparα
(Mm00440939_m1). The TaqMan primers for the housekeeping genes
are as follows: 18s (catalog number: 4319413E) and Gusb
(Mm00446953_m1). Primers for SYBR assays include the following:
Cidea, CAAACCATGACCGAAGTAGCC and AACCAGGCCAGTTGTGATGAC;
Acot11, GATCATGGCTTGGATGGAGAA and GGCCTCGGAAATGGAACAT;
Errα, CTCTGGCTACCACTACGGTGTG and AGCTGTACTCGATGCTCCCCT;
Mcpt1 ATCATGTATCGCCGCAAACT and CCATCTGGTAGGAGCACATGG.
Primers for Col18a1 that detects long, medium short, and all isoforms
were as published (Aikio et al., 2014). The SYBRprimer sets used as endog-
enous controls are as follows: Gusb, GTGAGCAACGCCAAATATGATG and
TCCAAATGCCCATAGTCATGATAC; 18s, GATCCATTGGAGGGCAAGTCT and
CCAAGATCCAACTACGAGCTTTTT; Rplp0, AGATGCAGCAGATCCGCA and
GTTCTTGCCCATCAGCACC.
2.12. RNA-seq Analysis and CIBERSORT
Library preparation and sequencing were performed by the IMB Se-
quencing Facility at the University of Queensland. Total RNA sample li-
braries were generated using the Illumina TruSeq Stranded mRNA LT
sample preparation kit (Illumina, Part no. RS-122-2101 and RS-122-
2102), according to the standard manufacturer's protocol (Part no.
15031047 Rev. E October 2013). The mRNA denaturation and elution
was performedwith 0.1 μg to 0.2 μg of total RNA (depending on amount
of sample available) prior to a heat fragmentation step aimed at produc-
ing librarieswith an insert size between 120 and 200 bp. cDNAwas then
synthesized from the enriched and fragmented RNA using SuperScript
III Reverse Transcriptase (Invitrogen, Catalog no. 18064014) and ran-
dom primers. The resulting cDNA was converted into double stranded
DNA in the presence of dUTP to prevent subsequent ampliﬁcation of
the second strand and thus maintain the strandedness of the library.
Following 3′ adenylation and adaptor ligation, libraries were subjected
to 15 cycles of PCR to produce RNA-seq libraries ready for sequencing.
Prior to sequencing, RNA-seq libraries were qualiﬁed via the Agilent
Bioanalyzer with the High Sensitivity DNA kit (Integrated Sciences,
Part no. 4067-4626). Quantiﬁcation of libraries for clustering was per-
formed using the KAPA Library Quantiﬁcation Kit - Illumina/Universal
(KAPA Biosystems, Part no. KK4824) in combination with the Life Tech-
nologies Viia 7 real-time PCR instrument. Sequencing was performed
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Time Analysis v2.1) platform. The library pool was diluted and dena-
tured according to the standard NextSeq500 protocol and sequencing
was carried out to generate single-end 76 bp reads using a 75 cycle
NextSeq500 High Output reagent Kit (Catalog # FC-404-1005). Reads
were aligned to GRCm38.p2 (Mus musculus) using STAR (Dobin et al.,
2013), and read counts for each gene in the Ensembl annotation were
generated using htseq-count in the HTSeq python package (Anders et
al., 2015) and the GENCODE annotation (Harrow et al., 2012). Differen-
tial gene expression was detected using the DESeq2 (Love et al., 2014)
packages in R. To quantify the relative expression levels of distinct cell
types from complex tissues, we utilized the CIBERSORT (Newman et
al., 2015). Variance stabilized transformed read count was generated
using the DESeq2 package (Love et al., 2014) and used as input data
for CIBERSORT. The LM22 signature was selected as a default parameter
and CIBERSORT was run with 100 permutation. Although the tool and
the embedded LM22 signature dataset were not designed for interro-
gating RNA-seq data, the authors note that “the linearity assumptions
made by our method are likely to hold, as previously suggested”. Enrich-
ment scores were transferred into the stack format as published
(Newman et al., 2015).
2.13. Ingenuity Pathway Analysis
The canonical pathways and functional analyses were generated
through the use of IPA (Ingenuity Systems) from the differential expres-
sion gene data set acquired from RNA-seq analysis. In the context of the
identiﬁcation of activation or inhibition of pathways, the z-score algo-
rithm matches the direction of gene changes with expected activated/
inhibited state in the canonical pathways (orange indicates predicted
activation/positive z-score and blue indicates predicted inhibition/neg-
ative z-score).
2.14. Database for Annotation, Visualization and Integrated Discovery (DA-
VID) Analysis
The entire gene list of signiﬁcantly regulated genes identiﬁed from
the RNA-seq analysis was uploaded onto the web documentation of
DAVID. Included in the documentation is a modiﬁed Fisher exact prob-
ability for ‘over-represented’ or most relevant biological terms associat-
ed with the given gene list where P b 0.05 was considered signiﬁcant
(Huang da et al., 2009). Datawas extracted after DAVID annotates, orga-
nizes and condenses the data into meaningful biological functions that
are associated with the gene list provided.
2.15. Statistical Analyses
Statistical analyses for all other analyses not included in the RNA-seq
workﬂow were performed using GraphPad Prism version 5.0
(GraphPad Software, San Diego, USA). In general, signiﬁcance was cal-
culated using unpaired two-tailed Student's t-tests or two-wayANOVAs
with Bonferroni's post-tests where applicable. Correlation analysis was
tested in an assumption-free model and the R2 value reports the Pear-
son correlation coefﬁcient. The associated P-value testswhether the cor-
relation effect between groups could be due to random sampling. A
small P-value allows for the rejection of the null hypothesis that the cor-
relation is due to random sampling.
3. Results
3.1. Transgenic Overexpression of RORα4 in Adipose Tissue
Our previous reports investigating the (global) Rorα-deﬁcient stag-
gerer sg/sgmouse model, and a transgenic muscle-speciﬁc line express-
ing dominant negative RORα indicated that this NR regulates glycemic
control and Akt2 signaling. Further studies in the sg/sg mouse modelindicated this NR regulated fat deposition, and responses to dietary
challenges. We were interested in further investigating the speciﬁc in
vivo functional role(s) of RORα signaling in adipose tissue, a major pe-
ripheral tissue involved in energy storage. Therefore, we pursued
targeted adipose-speciﬁc expression of RORα in transgenic mice. We
selected the RORα4 isoform for transgenic expression, because qPCR
analysis of subcutaneous, visceral and brown adipose tissues from
wild-type (WT) C57BL/6 mice clearly demonstrated that of the two iso-
forms expressed in rodents (RORα1 and α4), RORα4 was the most
abundantly expressed isoform in the three adipose tissue depots
(Fig. 1A).
RORα is a constitutively active NR, andwe conﬁrmed the (transcrip-
tional) activity of native RORα4 by examining its ability to transactivate
a well-characterized RORα dependent reporter gene (mPCP2tkluc)
(Supplementary Fig. 1A). We produced transgenic mice that selectively
express a transgene encoding a native (human) RORα4 expressing con-
struct driven by fatty acid binding protein 4 (FABP4) promoter (also
known as adipocyte protein 2) to achieve adipose-speciﬁc expression.
To validate the selective expression of the transgene in adipose tissues,
RNA from major organ/tissues (skeletal muscle, liver, kidney and
spleen), including inguinal, epididymal and interscapular fat tissue
representing the subcutaneous, visceral and brown adipose depots,
was extracted from male WT and transgenic [heterozygous (tg/+) Tg-
FABP4-RORα4] mice, and ectopic RORα4 transgene expression was ex-
amined via quantitative real-time PCR (qPCR) relative to 18s rRNA
(Fig. 1B). The heterozygous transgenic mice selectively, predominantly,
and abundantly expressed the ectopic human transgene (Fig. 1B),
resulting in signiﬁcantly increased total (i.e. endogenousmouse and ec-
topic human) RORα expression (Fig. 1C) in adipose tissues from tg/+
mice relative to WT littermate pairs.
As expected, signiﬁcantly lower transgene expression was observed
in the non-adipose tissues (quadriceps muscle, liver, spleen, and kid-
ney) compared to the adipose tissues. For example, ectopic RORα4 ex-
pression was N50- and N500-fold greater in SAT, relative to spleen
and liver, respectively. Western blot analysis was performed to validate
RORα overexpression using the proteins from the nuclear fractions ob-
tained from inguinal adipose tissues ofWT and heterozygote tg/+mice.
We showed that total RORα protein is expressed at a higher level (by
~8-fold) in heterozygote transgenic mice (tg/+) relative toWT siblings
in n=2 littermate pairs (Supplementary Fig. 1B and C). Thus using the
published FABP4 promoter (He et al., 2003) for driving adipose expres-
sion, we have successfully generated an adipose-speciﬁc RORα trans-
genic mouse line (Tg-FABP4-RORα4).
3.2. Adipose-speciﬁc RORα4 Transgene Expression Decreases Weight Gain
and Subcutaneous Adiposity
We hypothesized that RORα overexpression in adipose would per-
turb energy storage andhomeostasis. Hence,we comparedmice on nor-
mal chow and high fat diets (HFD), and examined growth, organ
weights, fat deposition etc., after an initial phase where normal chow
diet (b10% of total calories from fat) was fed ad libitum for 16 weeks,
and a second phase where the diet was switched to an energy-dense
HFD (~40% of energy from fat) for 14–16 weeks (Fig. 1D). The control
cohort remained on chow for the entire duration.
During the growth phase (4–14 weeks of age), comparable weight
gain was observed between transgenic (FABP4-RORα4) heterozygous
tg/+ (Fig. 1E) and homozygous tg/tg mice (Supplementary Fig. 2B)
compared to WT littermates on a normal chow diet. We detected no
dramatic morphological abnormalities and the tissue weights (normal-
ized to total body weight) of the three adipose depots examined were
similar (from 16 week old mice) inWT, tg/+ (Fig. 1F and G) or tg/tg lit-
termates (Supplementary Fig. 2C), and did not display any signiﬁcant
differences. We conclude that the FABP4-RORα4 transgene did not
overtly effect the growth or fat deposition in the three adipose depots
of tg/+ or tg/tg littermate mice maintained on normal chow diet.
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Fig. 1.Human RORα4 transgene tissue speciﬁcity, growth curve and tissue weights ofWT versus Tg-FABP4-RORα4mice on normal chow. (A–C) RNAwas extracted from selected tissues
(kidney, quadricepsmuscle, liver, SAT (inguinal fat), visceral adipose (epididymal fat) and brownadipose (interscapular fat), and examined for relative gene expression of (A) endogenous
(mouse) Rorα1 and Rorα4, (B) the transgene (human RORα4) and (C) total RORα (mouse and human) compared to the endogenous control (18s) using real-time PCR (n=3 littermate
pairs in duplicate experiments). Statistical analyses were performed using unpaired two-tailed Student's t-test for (A) and two-way ANOVAswith Bonferroni's post-test applied for (B–C)
where *P b 0.05; **P b 0.01; ***P b 0.001. (D) Schematic timeline of diet regime employed. (E) Body weight (in grams) of maleWT (black) and tg/+ (red) mice (n= 18 littermate pairs)
measured weekly up to 14 weeks of age. Statistical analyses were performed using two-way ANOVAs with Bonferroni's post-test applied but results were not signiﬁcant. (F)
Representative images of dissected WT and tg/+ littermate pair (chow diet). (G) Mean relative mass/total weight ± S.E.M. of adipose tissues dissected fromWT and tg/+ mice (n= 7
littermate pairs). Statistical analyses were performed on each tissue using unpaired two-tailed Student's t-test was performed where *P b 0.05.
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high fat diet (HFD) and examined from 17 to 32 weeks of age (relative
to chow diet fed mice as controls). After 8 weeks on HFD, both WT
and heterozygous tg/+ mice displayed signiﬁcant increases in weight
gain (by ~50%) when compared to their respective chow-fed controls
(chow-fed for the same duration) (Fig. 2A and B). However, between
HFD-fed WT and tg/+ littermate pairs, we observed a marked and sta-
tistically signiﬁcant divergence in weight gain from week 28 (approxi-
mately 10 weeks into the diet) and by week 30, tg/+ mice averaged
4 g less in weight than WT littermates (Fig. 2C). In corresponding sets
of mice on a normal chow diet, for the same duration, the tg/+ mice
trended toward less weight gain compared to WT littermates (Fig.
2D), however, this observation did not attain signiﬁcance. Thus trans-
genic mice appear to be leaner on a HFD. Gross anatomical examination
of frontal views of mice after dissection revealed a striking decrease in
subcutaneous fat deposition in the HFD-fed tg/+ mice relative to WTlittermates (Fig. 2E). The difference in adiposity for the HFD-fed tg/+
mice is corroborated by an independent measurement of total body
fat and lean mass percentage using nuclear magnetic resonance
(NMR) scanning. This NMR analysis was performed prior to dissection
on non-fasted, live, HFD-fed mice, and showed a signiﬁcant ~25% de-
crease in percentage total body fat of tg/+ mice relative to WT litter-
mate pairs (with a corresponding increase in percentage total lean
mass) (Fig. 2F andG). Adipose depotweight analysis conﬁrmed a signif-
icant ~40% decrease in the tissue weight of the SAT from HFD fed tg/+
mice relative to the corresponding tissue from WT littermate pairs
(Fig. 2H). However, there were no such respective differences in
weights of other adipose tissues examined [visceral (epididymal) adi-
pose tissue andbrown (interscapular) adipose tissue] (Fig. 2H). This sig-
niﬁcantly decreased subcutaneous depot mass in the tg/+ relative to
WT littermates on theHFDwas further conﬁrmedby examining the cor-
relation between the visceral (epididymal) vs. subcutaneous (inguinal)
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Fig. 2.Growth curve ofWT and tg/+Tg-FABP4-RORα4mice onHFD andmeasurement of adiposity. (A–D)Averageweight gain±S.E.M ofWT (black) and tg/+ (red)mice. Growth curves
plotted to compare HFD and chow diet in (A) WT mice and (B) tg/+ mice separately. (C) HFD growth curve on tg/+ mice relative to WT (solid circles, n= 10 littermate pairs) with
commencement of HFD at week 17. (D) Parallel growth curve data of WT and tg/+ mice on chow diet (hollow circles, n = 7 littermate pairs). Statistical analyses were performed
using two-way ANOVAs with Bonferroni's post-test applied where *P b 0.05; **P b 0.01; ***P b 0.001. Representative images of (E) dissected WT and tg/+ littermate pair at the end of
the HFD study (32-week). (F–G) NMR scans were performed on non-fasted live WT and tg/+ littermate pairs (HFD) and represented as the mean ± S.E.M. (F) percentage total body
fat and (G) percentage lean mass relative to total body weight from n= 8 littermate pairs of mice. (H) Mean relative mass/total weight ± S.E.M. of adipose tissues dissected fromWT
and tg/+ littermate pairs after HFD (n = 9 littermate pairs). Statistical analysis was performed using unpaired two-tailed Student's t-test where **P b 0.05. (I–J) Assumption-free
correlation analysis of visceral and SAT mass in (I) chow 32-week study (n= 7 littermate pairs) and (J) HFD study (n= 10 littermate pairs). The Pearson correlation R2 value reports
the fraction of “shared” variance while the P value tests the null hypothesis that there is no linear trend between the groups, where a small P value indicates a statistical signiﬁcant
linear trend.
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and HFD (Fig. 2J), respectively. We ﬁtted the data points using correla-
tion analysis and it demonstrated the attenuated capacity of the tg/+
subcutaneous adipose depot to expand in the face of a HFD challenge,
in contrast to theWT littermate (Fig. 2J). If the overall slopes were iden-
tical during the HFD challenge, there is a ~1.4% chance of randomly
choosing data points that will ﬁt identical slopes, concluding that the
differences between the slopes are signiﬁcant. In contrast, mice fed a
chowdiet in parallel did not presentwith any observable (and/or signif-
icant differences; ~86% chance of randomly choosing data points that
will ﬁt the current slope) in fat deposition in WT and tg/+ littermates
on the chow diet (Fig. 2I and Supplementary Fig. 1C and D). This type
of correlation analysis has been employed previously to characterize
depot speciﬁc adipose expansion (Jeffery et al., 2016).
In summary, our initial observations suggested that adipose-speciﬁc
RORα4 overexpression prevented overall weight gain by limiting pre-
vents subcutaneous fat expansion and deposition on a high fat diet.
The potentially selective effect of the FABP4-RORα4 transgene on SAT
fat deposition and expansion, i.e. a selective SAT lipodystrophy, is of par-
ticular interest in the light of pre-clinical studies indicating removal of
SAT induces glucose intolerance (Gentile et al., 2015), and that intra-abdominal subcutaneous fat transplantation reverses glucose intoler-
ance induced by an energy-dense diet (Hocking et al., 2015).
3.3. Adipocytes From tg/+ Subcutaneous Fat Tissue Are signiﬁcantly De-
creased in Median Size
We further characterized HFD-induced fat deposition in different
types of adipose tissues at a cellular level, by measuring the cross-sec-
tional area of adipocytes in hematoxylin and eosin (H&E)-stained sec-
tions of SAT from WT and heterozygous tg/+ mice. Staining revealed
that adipocytes from the SAT fat pad in tg/+mice were smaller relative
to respective cells inWT littermate tissues (Fig. 3A). This difference was
conﬁrmed by quantiﬁcation,with tg/+micedisplaying a higher propor-
tion of adipocytes with smaller cell area and a signiﬁcant decrease
(~50%) in median area relative to WT littermates (Fig. 3B). This pheno-
type was not observed in visceral adipose tissue, rather epididymal ad-
ipocytes fromWT and tg/+mice had a similar cross-sectional area (Fig.
3C and D). The predictable hyperplasia in response to high fat diet feed-
ing observed in adipocytes from the visceral compartment indicated
that tg/+ mice did not have a generalized lipid storage defect, rather
that excess lipids were being directed away from SAT depots.
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Fig. 3.H&E staining of adipose tissue and weights of non-adipose tissues in HFD-fedWT and tg/+ Tg-FABP4-RORα4mice. (A) Representative images ofWT and tg/+ SAT stained by H&E.
(B) Quantiﬁcation of cross sectional area of ~300 inguinal adipocytes from n=4 littermate pairs ofWT and tg/+mice is shown as a histogram of the relative frequency of adipocyte sizes
with bin intervals of 1000 μm2 and mean and median area measurements. (C) Representative images of WT and tg/+ visceral epididymal adipose tissues stained by H&E. (D)
Quantiﬁcation of cross sectional area of ~300 epididymal adipocytes from n= 4 littermate pairs of WT and tg/+ mice is shown as a histogram of the relative frequency of adipocyte
sizes with bin intervals of 2000 μm2 and mean and median area measurements. Signiﬁcance was calculated using unpaired two-tailed Student's t-test where *P b 0.05. (E)
Representative image of liver dissected from chow-fed 32-week old WT and tg/+ mice. (F) DEXA scanning of dissected livers from chow-fed WT and tg/+ mice (n = 7 littermate
pairs). (G) Mean relative mass/total weight ± S.E.M. of non-adipose tissues (liver, spleen and quadriceps muscle) dissected from chow-fed 32-week old WT and tg/+ littermate pairs
(n = 7 littermate pairs). (H–I) Representative images of (H) liver and (I) spleen dissected from HFD-fed WT and tg/+ mice. (J) Mean relative mass/total weight ± S.E.M. of non-
adipose tissues (liver, spleen and quadriceps muscle) dissected from WT and tg/+ littermate pairs after HFD (n = 9 littermate pairs). Statistical signiﬁcance was calculated using
unpaired two-tailed Student's t-test for where *P b 0.05; **P b 0.01.
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and Splenomegaly
The selective decrease in inguinal (i.e. subcutaneous) adiposity after
HFD in Tg-FABP4-RORα4 transgenicmicewas somewhat unexpected as
previous studies from our group and others reported decreased totaladiposity in the homozygous (global) Rorα-deﬁcient sg/sgmouse line
on both normal chow and HFD (Lau et al., 2008, 2015; Kang et al.,
2011). However, in the chow-fed study comparing non-adipose tissues
between WT and tg/+ mice, we noted that 32 week old tg/+ mice
displayed a modest decrease in relative quadriceps muscle mass
(~15%) and a pronounced enlargement of the liver and spleen (both
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sorptiometry (DEXA) scanning of livers from this cohort of chow-fed
mice, conﬁrmed signiﬁcantly increased fat composition (by ~30%) in
tg/+ livers compared to those of WT littermates (in contrast to no
changes in the liver lean mass composition) (Fig. 3F).
An even more striking hepatomegaly and splenomegaly was ob-
served in HFD fed tg/+ mice (Fig. 3H–J). Quantiﬁcation conﬁrmed the
signiﬁcant weight increase of the liver and spleen in tg/+ mice on
HFD relative toWT littermates (n=9–10) (Fig. 3J). Notably, quadriceps
muscles were not signiﬁcantly different in weight between WT and tg/
+ mice on a HFD (Fig. 3J).
Collectively, results from the extended chow study point to an age-
dependent effect of transgenic FABP4-RORα4 overexpression on hepat-
ic and splenic lipid loading. Due to the lipodystrophy observed in the
SAT and the hepatomegaly after HFD, we focused our subsequent atten-
tion on the contribution of these tissues to the overall phenotype of the
transgenic model.
It has been shown that SAT modulates liver triglyceride accumula-
tion (Hocking et al., 2015). Moreover, failure to sustain or expand ade-
quate subcutaneous fat storage adversely impacts glucose tolerance
and contributes to ectopic fat accumulation in non-adipose organs
such as the liver, increasing susceptibility to inﬂammatory stress and
cancer (Gentile et al., 2015; Hocking et al., 2015; Wree et al., 2011). To
gain a histological perspective of the changes in fat deposition of tg/+A
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Fig. 4. Trichrome staining of HFD livers and glycemic challenge of WT and Tg-FABP4-RORα4 m
sectioned at 0.7 μm-step intervals and stained for (A) collagen using Masson's trichrome st
staining (blue). Representative images acquired from n = 4 littermate pairs are shown. (B
16 weeks chow-fed WT and tg/+ mice (n= 6 littermate pairs). Signiﬁcance was calculated us
from 6 h-fasted WT (white) and tg/+ (black) (n = 10 littermate pairs) mice in the chow st
peritoneal administration of (E) glucose or (F) insulin (t= 0) on 6 h-fasted WT (black) and tg
from 6 h-fasted WT (white) and tg/+ (black) mice (n = 5 littermate pairs) in the HFD
administration of (H) glucose or (I) insulin (t= 0) on 6 h-fasted WT (black) and tg/+ (red) m
unpaired two-tailed Student's t-test for panels D and G and two-way ANOVAs with Bonferro
Plasma insulin levels of (i) 6 h-fasted (n = 5 littermate pairs) and (ii) overnight fasted WT
analysis was performed using unpaired two-tailed Student's t-test but comparisons were no
study (n= 8 littermate pairs). Statistical analysis was performed using unpaired two-tailed Stlivers, we performed H&E staining on deparafﬁnized liver sections
from HFD-fed WT and tg/+ mice to identify signiﬁcant morphological
differences. We observed a striking increase in vacuole-like lipid bodies
in tg/+ liver relative to WT littermates (Supplementary Fig. 3A), sug-
gesting increased lipid storage in the tg/+ livers could be involved in
hepatomegaly (Fig. 3E and H).
In the liver, steatosis can be accompanied by ﬁbrosis. To check for de-
velopment of ﬁbrosis in the tg/+ livers, we performed Masson's
trichrome staining to visualize collagen accumulation, a hallmark of ﬁbro-
sis. In both WT and tg/+ livers of mice (fed on a HFD for 14 weeks) we
observed signs of portal vein collagen accumulation with no signs of cen-
tral ﬁbrosis occurring in both strains of mice (Fig. 4A). A modest increase
in collagen-positive portal veins/sites in transgenic liverwas present, con-
sistent with early, mild portal ﬁbrosis (Fig. 4A).
In summary, we observed the development of hepatomegaly and
splenomegaly with FABP4-RORα4 transgene overexpression on chow
diet. Upon HFD challenge, transgenic mice displayed decreased total
body weight associated with a speciﬁc decrease in subcutaneous adi-
posity, and hepatomegaly was further exacerbated. DEXA and histolog-
ical analyses of transgenic livers showed increased lipid accumulation.
Thiswas accompanied by signiﬁcantly increased levels of circulating tri-
glycerides and NEFA's in the Tg/+ mice (relative to WT littermates) on
the chow diet (Fig. 4B and C); however, the blood lipid proﬁles on the
HFD were not signiﬁcantly different (data not shown). Interestingly,E F
H I
K
ice. (A) Formalin-ﬁxed and parafﬁnized liver tissues of HFD-fed WT and tg/+ mice were
aining. Red denotes cytoplasmic staining and the yellow arrowheads indicate collagen
and C) Analysis of mean ± S.E.M. fasting plasma (B) triglyceride and (C) NEFAs from
ing unpaired two-tailed Student's t-test where *P b 0.05. (D) Fasting blood glucose levels
udy (16 weeks old). (E and F) Blood glucose was measured at various times after intra-
/+ (red) mice (16 week chow, n= 10 littermate pairs). (G) Fasting blood glucose levels
study. (H and I) Blood glucose was measured at various times after intra-peritoneal
ice in the HFD study (n= 5 littermate pairs). Statistical analyses were performed using
ni's post-test applied for panels E, F, H and I where *P b 0.05; **P b 0.01;***P b 0.001. (J)
and tg/+ littermates (n = 8 littermate pairs) from the 32-week chow study. Statistical
t signiﬁcant. (K) Plasma insulin levels of overnight fasted WT and tg/+ mice in the HFD
udent's t-test but comparisons were not signiﬁcant.
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warranting more rigorous characterization of this phenotype. Thus the
effect of HFD challenge was to alter the energy storage response in the
tg/+ mice from the traditional lipid depots (adipose tissues) to non-
conventional sites such as the liver, imposing additional stress on
these organs. This indicates a poor prognosis for the tg/+ mice because
disorders in adipose fat storage function can lead to increased liver
steatosis, glucose intolerance and cancer (Wree et al., 2011). Conse-
quently, we investigated the association between aberrant energy stor-
age and glycemic control in the FABP4-RORα4 transgenicmousemodel.3.5. Glucose Intolerance in Tg-FABP4-RORα4 Mice
Previous studies on the global Rorα-deﬁcient staggerer (sg/sg) mu-
tantmice revealed overall improved glucose tolerance and increased in-
sulin sensitivity (Lau et al., 2011). Hence we examined the effect of
adipose-speciﬁc RORα transgene expression on these parameters.
Compared to their WT counterparts, both tg/+ (heterozygous)
(Fig. 4D) and tg/tg (homozygous) (Supplementary Fig. 2D) Tg-
FABP4-RORα4 transgenic mice fed on normal chow diets exhibited
elevated blood glucose levels after a 6 h fast. We further examined
systemic glucose metabolism and insulin sensitivity by performing
intraperitoneal glucose tolerance tests (GTTs) and insulin tolerance
tests (ITTs). Although blood glucose levels in tg/+ mice peaked at a
similar level to WT littermate mice, glucose clearance was impaired
at the later timepoint – remaining ~40% higher than WT littermates
at the end of the time course (Fig. 4E). Interestingly, glucose clear-
ance in the homozygous tg/tgmice (that we could only obtain in lim-
ited number) was markedly impaired with a signiﬁcant increase in
peak blood glucose levels (~30%) after glucose challenge and
sustained higher blood glucose levels were recorded throughout
the time course (Supplementary Fig. 2E). The blood glucose level in
tg/tg mice was ~65% higher than WT littermates at the end of the
time course (Supplementary Fig. 2E). In contrast, WT, tg/+ (Fig.
4F) and tg/tg (Supplementary Fig. 2F) mice showed similar respon-
siveness to intraperitoneal insulin, indicating normal insulin action
in the transgenic mice. Furthermore, plasma insulin levels in 6 h
and overnight fasted tg/+ mice were not signiﬁcantly different
than the comparable levels in WT mice [Fig. 4J(i and ii)]. Preliminary
intraperitoneal pyruvate tolerance testing also revealed no signiﬁ-
cant differences between WT and tg/+ littermates (data not
shown), allowing us to exclude alterations in hepatic gluconeogene-
sis as a contributor to the impaired glucose clearance observed dur-
ing IP glucose challenge.
In the HFD study, tg/+ mice also displayed signiﬁcantly higher
fasting blood glucose levels (~20% higher) relative to WT littermates
(Fig. 4G). After intraperitoneal administration of glucose, both WT and
tg/+ mice showed similar peak blood glucose levels (~30% increase
compared to those on chow diet) and the impairment in glucose clear-
ance (Fig. 4H). However, this was more pronounced compared to data
from the chow study in Fig. 4E (blood glucose level in HFD tg/+ mice
was ~50% higher than WT littermates at the end of the time course).
While tg/+ mice did appear to be less sensitive to insulin administra-
tion, this trend did not attain signiﬁcance (Fig. 4I). Fasted plasma insulin
levels were also not signiﬁcantly different between WT and tg/+ mice
(Fig. 4K. Therefore, the impairment to glucose tolerance in Tg-FABP4-
RORα4 mice appears to be independent of insulin action.
In summary, these results demonstrated a dose-dependent negative
effect of adipose-RORα expression on whole body glucose clearance –
an effect thatwas ampliﬁed in the context of high fat diet. It is intriguing
to speculate whether the SAT lipodystrophy that is observed in this
model contributes to compromised glucose tolerance as other studies
have indicated it is essential for the maintenance of glycemic control
under both normal and high fat dietary conditions (Gentile et al.,
2015; Hocking et al., 2015).3.6. Insights Into the Molecular Pathways Underlying the SAT
Lipodystrophy and the Hepatomegaly Phenotype in the Tg-FABP4-RORα4
Mice
In an effort to gainmolecular insights into the SAT lipodystrophy and
hepatomegaly, accompanied by glucose intolerance (in the absence of
changes in whole body insulin sensitivity, we undertook broad-scale
(qPCR and RNA-seq) transcriptional proﬁling of SAT and the liver in
order to identify changes in underlying molecular pathways.
3.6.1. Subcutaneous Adipose Gene Expression in Tg-FABP4-RORα4 Mice
Our strategy to identify the gene expression patterns underlying the
selective SAT lipodystrophy involved a bifurcated approach, that inves-
tigated: (i) speciﬁc differences in subcutaneous relative to visceral adi-
pose in the transgenic mouse, and (ii) differences in SAT in the
transgenic relative to WT mice.
Initially, we examined the differential expression of genes in subcu-
taneous relative to visceral adipose (by qPCR) in the transgenic model
thatmay inﬂuence lipid homeostasis and glycemic control. This analysis
identiﬁed signiﬁcantly decreased expression of several critical genes
that drive fatty acid biosynthesis, and lipid droplet expansion including
Acs14, Dgat2, Fasn and Scd2 in SAT relative to visceral adipose tissue
from the Tg-FABP4-RORα4 (Fig. 5A–D). Moreover, we observed signiﬁ-
cantly decreased expression of the Rab-GTPase-activating proteins
(Rab-GAPs), Tbc1d1 and AS160/Tbc1d4 (Fig. 5E and F) in the Tg-
FABP4-RORα4 SAT. Decreased expression of Rab GTPase-activating pro-
teins has been reported to correlate with decreased glucose tolerance in
an intraperitoneal GTT assay, aberrant glucose uptake and dysfunctional
carbohydrate and energy homeostasis (Hargett et al., 2016; Chadt et al.,
2015). Furthermore, we observed decreased Rab18 expression (that
failed to attain signiﬁcance, P= 0.06), which has been associated with
impaired fat storage (Pulido et al., 2011), and aberrant processing of
lipids in adipose tissue (Pulido et al., 2013) (Fig. 5F). In summary, this
analysis identiﬁed the differential expression of several critical genes
in SAT (relative to visceral adipose) that provided some insights into
the subcutaneous lipodystrophic and glucose intolerant phenotype in
the Tg-FABP4-RORα4.
To gain further insights we examined the differential expression of
several metabolic genes that may contribute to decreased SAT deposi-
tion/expansion (on HFD) in the Tg-FABP4-RORα4 mouse model, rela-
tive to WT littermates. We uncovered several gene changes that are
consistent with elevated lipid mobilization and catabolism in the SAT.
For example, we identiﬁed signiﬁcant up-regulation of the gene
encoding carnitine palmitoyltransferase 2 (Cpt2) in the adipose tissue
of heterozygote tg/+ mice (Fig. 6A). Cpt2 catalyzes rate-limiting steps
in fatty acid uptake and oxidation by mitochondria (Bonnefont et al.,
2004; Jogl et al., 2004). In addition, we also observed signiﬁcant up-reg-
ulation of patatin-like phospholipase domain containing 2 [Pnpla2, also
known as adipose triglyceride lipase (ATGL)] in tg/+ SAT (Fig. 6B).
PNPLA2/ATGL is the rate-limiting enzyme that catalyzes the hydrolysis
of triglycerides and plays a key role in lipid droplet degradation
(Smirnova et al., 2006). Moreover, we observed increased expression
of the mRNAs encoding the β3-adrenergic receptor (Adrb3) (Fig. 6C)
in concordance with increased lipolysis and fatty acid utilization
(Ghorbani et al., 1997; Granneman et al., 2005; Mottillo et al., 2010).
Furthermore, the gene that encodes one of the critical NADH dehydro-
genases that are part of the mitochondrial complex I machinery
(Ndufb5) was signiﬁcantly up-regulated in the SAT of Tg-FABP4-
RORα4 tg/+ mice (Fig. 6D). Differential and increased expression of
Cpt2, Pnplas/ATGL, Adrb3, and Ndufb5 is entirely concordant with in-
creased lipid mobilization and utilization in the SAT from Tg-FABP4-
RORα4 tg/+mice, andwould contribute to decreased fat deposition/ex-
pansion in this depot bymice that overexpress RORα4 in adipose tissue.
We subsequently investigated gene expression associated with
adaptive thermogenesis in the brown adipose tissue from the Tg-
FABP4-RORα4 transgenic mouse model, relative to WT littermates.
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Fig. 5. Taqman low density array (TLDA) analysis of mRNA expression fromSAT relative to
visceral adipose tissue of Tg-FABP4-RORα4 mice on a high fat diet. Relative gene
expression (normalized against Rplp0) of (A) Acsl4, (B) Dgat2, (C) Fasn, (D) Scd2, (E)
Tbc1d1, (F) Tbc1d4 and (G) Rab18. TLDAs performed as described (Pearen et al., 2012,
2013). Statistical analysis was performed on data acquired from n = 4 littermate pairs
using unpaired two-tailed Student's t-test where *P b 0.05; **P b 0.01; ***P b 0.001.
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Fig. 6. Taqman low density array (TLDA) analysis of mRNA expression from subcutaneous
adipose and brown adipose tissue from Tg-FABP4-RORα4 relative to WT mice. Relative
gene expression of (A–D) Cpt2, Pnpla2, Adrb3, Ndufb5, respectively in SAT from HFD fed
32-week tg/+ Tg-FABP4-RORα4 and WT littermates (from n= 4). TLDAs performed as
described (Pearen et al., 2012, 2013). and presented as relative gene expression
(normalized against Gusb). Relative gene expression of Ucp1 and Cidea, respectively in
brown adipose tissue from chow (E–F) and high fat diet (G–H) fed 32-week tg/+ Tg-
FABP4-RORα4 and WT littermates (n = 4). Quantitative PCR was performed on RNA
fractionated from interscapular brown adipose tissue, and measured Ucp1 and Cidea
expression (using Taqman and SYBR assays), and presented as relative gene expression
(normalized against Gusb, and Rplp0, respectively) in samples from 32-week chow (E–F)
and high fat diet fed (G–H) Tg-FABP4-RORα4 and WT littermates (from n = 5).
Statistical analysis was performed using unpaired two-tailed Student's t-test where
*P b 0.05; **P b 0.01; ***P b 0.001.
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sg/sgmice was associated with differential expression of the hierarchi-
cal adipose transcriptional regulators (Ehmt1, Tle3, Prdm16), increased
Ucp1 expression, and elevated expression of genes associated with the
induction of the thermogenic program (Lau et al., 2015). Therefore,
we performed qPCR analysis on selected key thermogenic regulatory
genes from chow-fed Tg-FABP4-RORα4 tg/+ mice, including Ehmt1,
Tle3, Prdm16, Ucp1 and the accompanying genes associated with ther-
mogenesis (e.g. Cidea, Acot11, Dio2, Errα, Pparα, and Mcpt1). We ob-
served no signiﬁcant differences in the mRNA expression of the
transcriptional regulators, Ehmt1, Tle3 and Prdm16 in brown adipose tis-
sue (Supplementary Fig. 4), but we observed a signiﬁcant decrease inthe expression of the mRNAs encoding Ucp1 (by ~60–70%) and Cidea
(by ~30–40%) in the brown adipose from Tg-FABP4-RORα4 tg/+
mice, relative to WT littermates on the chow and high fat diets, respec-
tively (Fig. 6E and F vs. Fig. 6G andH, respectively). However, we did not
observe any signiﬁcant differences in the expression of the other genes
involved in the thermogenic program in the brown adipose from Tg-
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high fat diets, respectively (Supplementary Fig. 4). The decreased ex-
pression of Ucp1, is consistent with increased Ucp1 mRNA expression
in the Rorα-deﬁcient sg/sgmousemodel, and provides further evidence
for the association betweenRORα signaling andUcp1mRNAexpression.
Moreover, decreased Cidea expression correlates with increased lipoly-
sis, and decreased triglyceride deposition/lipid droplet formation (Puri
et al., 2008). Overall, the lipodystrophic SAT phenotype in the Tg-
FABP4-RORα4 tg/+ mice is in accord with gene expression changes
that affect lipid homeostasis.
3.6.2. RNA-seq and Pathway Analysis
We subsequently performed genomewide RNA-seq expression pro-
ﬁling analysis on RNA collected from SAT and hepatic tissue to gain
deeper insights into the underlying molecular pathways. The analysis
identiﬁed N2400 genes/mRNA(total, after Benjamini andHochberg cor-
rection) that were differentially expressed in the SAT in a signiﬁcant
manner.We could also identify that RORαwas signiﬁcantly up-regulat-
ed by ~10-fold (P b 6.08 × 10−89) in tg/+ SAT (Supplementary Table 1,
highlighted in gray). In contrast, only ~70 genes (total, after Benjamini
and Hochberg correction) in the liver were differentially expressed in
a signiﬁcant manner (n = 3 littermate pairs). The top 50 up- and
down-regulated genes in SAT are listed in Supplementary Table 1 and
the up- and down-regulated genes in the liver are listed in Supplemen-
tary Table 1.
Ingenuity pathway analysis was performed to identify canonical
pathways and biological functions that were signiﬁcantly enriched
with differentially expressed genes from the RNA-seq analysis. This
was performed with a cut-off value of ≥±1.3 fold-change (~1800
genes after cut-off). Pathway analysis on SAT identiﬁed signiﬁcant en-
richment of differentially expressed genes involved in ~140 canonical
pathways in Tg-FABP4-RORα4 tg/+ mice. The analysis revealed that
the differentially expressed genes enrich approximately ~20% of each
pathway (Fig. 7A). The top 15 signiﬁcantly enriched canonical pathways
and biological functions are shown in Fig. 7A. These include (the most
highly rankedpathway) hepatic ﬁbrosis (P b 8.28×10−8). Interestingly,
the pathway analysis also identiﬁed signiﬁcant enrichment of functions
associated with endocrine disorders and metabolic diseases, corre-
sponding to glucose metabolism disorder (P b 5.62 × 10−24), insulin-
dependent diabetes mellitus (P b 2.39 × 10−21) and diabetes mellitus
(P b 1.44 × 10−19) and further predicts that diabetes mellitus is in-
creased (z-score = 2.303) (Fig. 7B). Interestingly, 10 out of the top 15
signiﬁcantly enriched canonical pathways are associated with immune
signaling and inﬂammatory response. In summary, this is in accord
with the phenotypes of impaired glucose clearance observed and high-
lights increased susceptibility in developing diabetes mellitus at the
transcript level with adipose-speciﬁc RORα expression.
Ingenuity pathway analysis of the liver is limited, identifying only 11
canonical pathways as signiﬁcantly enrichedwith the list of differential-
ly expressed genes fromRNA-seq analysis (~70 genes) betweenWTand
Tg-FABP4-RORα4 tg/+ hepatic tissue (Fig. 7C). Notably, hepatic ﬁbrosis
was the most signiﬁcant pathway in tg/+ liver (that displayed hepato-
megaly) as discussed previously. The pathway analysis and heatmap
depicted in Fig. 7D, also predicts that pathways associated with PPAR
signaling (P b 8.47 × 10−3) and PPARα activation (P b 4.69 × 10−2)
are inhibitedwhile IL-6 signaling pathway (P b 1.52 × 10−2) is activated
(Fig. 7C/D). PPARs are well-known NRs that play a central role in fatty
acidmetabolism (in particular lipid catabolism). IL-6 is a pro-inﬂamma-
tory cytokine and has been linked to development of hepatic steatosis
and hepatic insulin resistance (Sabio et al., 2008). These observations
in the hepatic tissue are in accord with increased lipid storage or possi-
ble tissue damage/ﬁbrosis in Tg-FABP4-RORα4 tg/+ livers. Moreover,
functional DAVID pathway analysis of the liver (Supplementary Fig.
3B) revealed signiﬁcant enrichment of functions that correspond to or-
ganization of collagen ﬁbrils (P b 3.59 × 10−13) and inﬂammation of
organ (P b 2.07 × 10−09).3.6.3. RORα4 Expression and Immunity in SAT
The association between RORα4 expression and immunity in adi-
pose tissue is underscored by the pathway analysis identiﬁcation of sig-
niﬁcant activation of T lymphocytes signaling pathways, including PKC-
θ signaling in T lymphocytes (~30% of pathway enriched, z-score =
2.502, P b 7.22 × 10−05) and inducible T-cell co-stimulator (ICOS)-
ICOS-ligand (ICOSL) signaling in T helper (Th) cells (~22% of pathway
enriched, z-score=2.673, P b 6.28× 10−4) (Fig. 8A-immune cell signal-
ing). The two signiﬁcantly enriched T-cell signaling pathways com-
prised of several overlapping genes suggest that inﬂammatory
signaling may be activated in the SAT of Tg-FABP4-RORα4 tg/+ mice
as a result of RORα4 overexpression. The heatmap in Fig. 8B details
the fold changes of the genes involved in the two pathways accompa-
nied with expected direction of gene changes when the immune re-
sponse pathways are activated. Thus, the gene changes identiﬁed in
the RNA-seq/pathway analysis of the SAT, highlight potential changes
associated with T-cell signaling and PKC-θ signaling in tg/+ SAT. Re-
cently, there have been several high proﬁle publications utilizing analyt-
ical tools to allow for the discrimination of cell subsets and cell
composition in complex tissues from their gene expression proﬁles
(Newman et al., 2015; Qi et al., 2014). We utilized the CIBERSORT
gene expression deconvolution analytical tool (Newman et al., 2015)
on our RNA-seq data and plotted the predicted relative frequency of
the immune cell subtypes contained in the LM22 signature into a
stacked format. CIBERSORT was able to identify a signiﬁcant increase
in CD4 T-cell signature (red) in the SAT from 3/4 of the tg/+ Tg-
FABP4-RORα4 mice relative to WT littermates (Fig. 8C and D).
3.6.4. RORα4 Expression, Fibrosis and Extracellular Matrix Remodeling in
SAT and Liver Tissue
Interestingly, the most signiﬁcant canonical pathway in both Tg-
FABP4-RORα4 tg/+ SAT (P b 8.28 × 10−8) and hepatic tissue
(P b 5.11 × 10−13) is hepatic ﬁbrosis (Fig. 7A and C). Although, there
is a contrast in the regulation of the genes between the two tissues,
this is in accordance with the phenotype. For example, many of the
genes that encode the extracellular matrix (ECM) collagen proteins
are down-regulated in the Tg-FABP4-RORα4 tg/+ SAT, but increased
in hepatic tissue (Fig. 9A). This is highlighted by the differential expres-
sion of collagens 4, 5, 6, 18, 19 and 23 (Fig. 9A), indicating ECM directed
molecular mechanisms are affecting fat deposition/energy storage in
adipose and liver. Collagen production and regulation is important for
adipose development and physiology, as well as adipose plasticity to
suitmetabolic demands and changes (Mariman andWang, 2010). In ad-
dition ECM reprogramming is necessary for adipose growth and expan-
sion on energy dense diets. In contrast, collagen production in liver is
associatedwith liver ﬁbrosis. The role of collagens in controlling adipos-
ity is highlighted by loss of collagen XVIII (18) (signiﬁcantly down-reg-
ulated in Tg-FABP4-RORα4 tg/+ SAT RNA-seq data) that results in
reduced adiposity, ectopic deposition of fat in the liver and hypertriglyc-
eridemia (Aikio et al., 2014). This effect was attributed to reduced fat
storage capacity due to perturbations in ECM remodeling and adipocyte
development associated with aberrant Wnt/β-catenin signaling (Aikio
et al., 2014). Therefore, we used qPCR to validate and demonstrate the
(~2–3-fold) signiﬁcantly decreased expression of the Col18a1 long, me-
dium and short isoforms in SAT (Fig. 9B). In contrast, no signiﬁcant dif-
ferences in expression were observed in visceral adipose tissue and
hepatic tissue (Fig. 9C andD). The recognized association between aber-
rant ECM and Wnt/β-catenin signaling in dysfunctional fat deposition
was underscored by the RNA-seq analysis in SAT, that identiﬁed signif-
icant down-regulation of the mRNA encoding secreted frizzled-related
protein 5 (Sfrp5) by ~5-fold (P b 8.55 × 10−56) (Supplemental Table
1, highlighted in gray). Sfrp5 is aWnt antagonist that is typically upreg-
ulated in adipose during diet-induced obesity. Quantitative PCR analysis
further highlighted the attenuated response of Sfrp5mRNA expression
to a high fat diet challenge in the Tg-FABP4-RORα4 relative to WT
mice, and the signiﬁcantly decreased expression of Sfrp5 mRNA
A C
B D
Fig. 7. RNA-seq and ingenuity pathway analysis of HFD inguinal adipose tissue and liver. RNA-seq was performed on RNA isolated from overnight fasted WT and Tg-FABP4-RORα4
(heterozygous) tg/+ mice that were in the HFD study (n= 4 littermate pairs). (A) The top 15 canonical pathways and biological functions enriched by differentially expressed genes
from the RNA-seq analysis comparing WT and tg/+ inguinal adipose tissues (HFD) highlighted by ingenuity pathway analysis. Ratio indicates the percentage of differentially
expressed genes per any given pathway and P-value threshold is set at P b 0.05 derived after Benjamini and Hochberg (B–H) multiple testing correction. (B) Signiﬁcantly enriched
metabolic functions. Orange bars indicate positive z-score (predicted activation) and gray bars indicate no prediction of activation/inhibition state. (C) Signiﬁcantly enriched canonical
pathways and top 10 biological functions associated with differentially expressed genes in tg/+ liver (HFD). (D) Gene expression changes in liver tissues of Tg-FABP4-RORα4 vs. WT
(n= 4 littermate pairs) comparing to expected expression direction of PPAR, IL-6 and PPARα/RXRα signaling activation.
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the high fat diet (Fig. 9E). Overall, the difference in Sfrp5 induction in
Tg-FABP4-RORα4 tg/+ mice supports the ﬁndings of reduced weight
gain associated with speciﬁc reduction of SAT fat deposition/expansion
in HFD-fed Tg-FABP4-RORα4 tg/+ mice, and further suggests that the
ability to expand the adipose tissue may be altered in these mice.
In summary, adipose speciﬁc transgenic RORα4 expression results in
the differential expression of collagen genes (in SAT and liver) that arecritical for ECM remodeling, and aberrant Wnt signaling - both of
which are the underlying factors in altered fat deposition in adipose
and hepatic tissues. This is in accord with the very recent study demon-
strating the fat microenvironment controls depot speciﬁc expansion
and tissue mass on obesogenic diets (Jeffery et al., 2016), and
obesogenic studies on Wnt signaling (Mori et al., 2012;
Gutierrez-Vidal et al., 2015). Furthermore, the two gene expression pro-
ﬁling approaches (qPCR and RNA-seq) identiﬁed differential expression
A B
C
D
Fig. 8. Activation of T-cell signaling and CIBERSORT analysis. (A) Signiﬁcantly enriched immune cell signaling functions in HFD tg/+ SAT. Orange bars indicate positive z-score (predicted
activation from ingenuity pathway analysis). (B) The heatmappresents differentially expressed in SAT fromTg-FABP4-RORα4 vs.WT (n=4 littermate pairs). Fold changeswere shown in
log2 scale with expected expression direction of PKC-θ and ICOS-ICOSL pathways (activation). (C–D) CIBERSORT analysis of SAT RNA-seq data for the quantiﬁcation of relative levels
(percentage) of 22 immune cell subtypes (LM22 gene signature). Relative percentages are plotted in a stacked format in (C). The data speciﬁc to memory resting CD4 T cells listed in C
(red module) was extracted and an unpaired two-tailed Student's t-test was performed to calculate for signiﬁcance where *P b 0.05.
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ECM remodeling, that are in accordwith hepaticﬁbrosis as themost sig-
niﬁcantly enriched pathway in Tg-FABP4-RORα4 tg/+ SAT and liver.
This provides molecular evidence supporting our observations of re-
duced subcutaneous adiposity, impaired glucose tolerance, ectopic fat
accumulation and liver ﬁbrosis. This phenotype highlights important
crosstalk between the adipose tissue and the liver, under the modula-
tion of adipose-speciﬁc ROR alpha expression.
4. Discussion
The sterol-sensing ‘orphan’ NR, RORα, is expressed in a number of
metabolically active tissues and cell types, including the adipose tissue,
muscle, resident tissue macrophages and lymphocytes (Bookout et al.,
2006). This NR has been implicated in the regulation of lipid homeosta-
sis and responses to energy dense diets. These factors, and the signiﬁ-
cance of lipid distribution in adipose depots and lean tissue suggested
a potentially important role for RORα in obesity and inﬂammation. Ad-
ipose tissue is important for the regulation of energy homeostasis, in
part due to its role in storing triglyceride and secretingmany endocrinesignaling proteins (Scherer, 2006). The local and systemic effects of
overexpressing RORα in the adipose tissues of Tg-FABP4-RORα4 mice
were examined herein.
Perhaps themost striking result from this study was that Tg-FABP4-
RORα4 mice demonstrated a remarkable shift in energy storage and fat
distribution from the SAT to non-adipose tissues when challenged with
a high fat diet (HFD). Speciﬁcally, we observed a subcutaneous
lipodystrophy associated with pronounced hepatomegaly and spleno-
megaly. These changes were also accompanied with decreased overall
weight gain and decreased total body fat percentage after HFD. De-
creased adiposity and reducedweight gainweremost probably a reﬂec-
tion of decreased fat deposition in the subcutaneous depot. Moreover,
we also observed signiﬁcantly higher fasting blood glucose levels and
impaired clearance of intra-peritoneally injected glucose in chow-fed
Tg-FABP4-RORα4 mice. The glucose clearance impairment was further
exacerbatedwhen Tg-FABP4-RORα4micewere placed on theHFD chal-
lenge. However, there were no apparent differences in insulin sensitiv-
ity, or circulating insulin levels. Histological analysis conﬁrmed
markedly increased accumulation of lipid bodies and signs of portal ﬁ-
brosis throughout the liver derived from Tg-FABP4-RORα4 mice. In
A B
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Fig. 9. Gene expression changes in the hepatic ﬁbrosis pathway and ECM regulation. (A) Heatmap of differentially expressed genes associated with hepatic ﬁbrosis. Data was extracted
from STAR-DESeq2 output (RNA-seq pipeline). Each column represents log2 fold-changes comparing SAT and liver tissues of Tg-FABP4-RORα4 vs. WT (n = 4 littermate pairs).
Relative gene expression of Col18a1 in (B) SAT, (C) visceral adipose tissue, and (D) liver, respectively from tg/+ Tg-FABP4-RORα4 and WT littermates in the HFD study (n = 4–5
littermate pairs). Quantitative PCR (utilizing SYBR primers) was performed on RNA fractionated from the tissues and presented as relative gene expression normalized against Rplp0.
Statistical analysis was performed using unpaired two-tailed Student's t-test where *P b 0.05; **P b 0.01; ***P b 0.001. (E) Relative gene expression of Sfrp5 in inguinal SAT from tg/+
Tg-FABP4-RORα4 and WT mice in the HFD study (n = 4 littermate pairs). Quantitative PCR was performed using TaqMan assays and presented as relative gene expression
(normalized against Gusb). Statistical analysis was performed using a two-way ANOVA with Bonferroni's post-test applied where ***P b 0.001; n.s. denotes non-signiﬁcant.
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splenomegaly and mild hepatomegaly at the end of the study, but do
not display changes to the adipose tissues and overall growth. This sug-
gests that the Tg-FABP4-RORα4 mice do not adapt appropriately to the
physiological challenges of an energy-dense diet in the context of lipid
storage and expansion of adipose tissue, but rather are associated with
aberrant energy storage and ectopic fat deposition in other (lean
mass) organs.
We utilized two approaches to understand the molecular mecha-
nisms underscoring the observed phenotype of subcutaneous
lipodystrophy with accompanying hepatic lipid accumulation and im-
paired glucose tolerance: targeted qPCR proﬁling of critical metabolic
genes and RNA-seq deep sequencing coupled with pathway analyses.
Focused qPCR analysis of critical metabolic genes in the transgenic
SAT (relative to the visceral adipose tissue) identiﬁed the selective and
signiﬁcantly decreased expression of several important genes that
drive fatty acid biosynthesis, and lipid droplet expansion including
Acs14, Dgat2, Fasn and Scd2 in SAT from the Tg-FABP4-RORα4 line. Fur-
thermore, we identiﬁed decreased expression of Rab 18 and the Rab-
GAPs, Tbc1d1 and AS160/Tbc1d4. This pattern of expression in adipose
tissue has been associated with impaired glycemic control, energy ho-
meostasis, and fat storage (Hargett et al., 2016; Chadt et al., 2015;
Pulido et al., 2013). The subcutaneous speciﬁc differential expression
of several critical genes provided some insights into the subcutaneous
lipodystrophic and glucose intolerant phenotype in the Tg-FABP4-
RORα4.
Moreover, additional qPCR proﬁling revealed the SAT lipodystrophy
in the Tg-FABP4-RORα4 mouse model is also associated with increased
lipid mobilization and catabolism (relative to WT littermates). For ex-
ample, we identiﬁed increased expression of the genes encoding Cpt2,
Pnpla2/ATGL and Adrb3 (Bonnefont et al., 2004; Jogl et al., 2004;
Smirnova et al., 2006; Ghorbani et al., 1997; Granneman et al., 2005;
Mottillo et al., 2010). This phenotype was coupled with decreased ex-
pression of the (adaptive) thermogenic driver, Ucp1, and Cidea (amark-
er of increased lipolysis) in brown adipose tissue. This was in accord
with increased Ucp1 and Cidea expression in the brown adipose from
RORa deﬁcient staggerer mice.
RNA-seq and pathway analysis identiﬁed differential expression of
many genes involved in lipid localization and transport, glucose metab-
olism disorder and diabetes in Tg-FABP4-RORα4 SAT. The analysis re-
vealed ﬁbrosis as the most signiﬁcant pathway in both the SAT and
liver. Interestingly, these two tissues display dysfunctional and aberrant
(and often reciprocal) regulation ofmRNAs encoding ECM collagen pro-
teins; collagen transcripts were down-regulated in the SAT and inverse-
ly up-regulated in the liver. Collagen (5, 6 and 18) production and
regulation has been implicated in adipose development and physiology,
as well as adipose plasticity to suit metabolic demands and changes
(Mariman and Wang, 2010). Aberrant regulation and expression of
the extracellular matrix has been demonstrated to drive perturbed adi-
pose reprogramming during obesity and ectopic fat accumulation (Tam
et al., 2012; Aikio et al., 2014), ECM-guidedmolecularmechanisms con-
trol the adipogenic pathways and adipocyte size. Speciﬁcally, decreased
collagen expression in the SAT is in accord with decreased adipocyte
size, decreased fat deposition and ectopic fat accumulation (Aikio et
al., 2014). In this context we observed the selective decrease in the ex-
pression of the mRNAs encoding the short, medium and long forms of
Col18a1 in SAT, but not in visceral adipose tissue or liver.
Furthermore, in this context we identiﬁed the signiﬁcantly de-
creased expression of (the Wnt antagonist) SFRP5. Down regulation of
Wnt signaling and gene expression are associated with adipogenic dif-
ferentiation (triglyceride storage), and Wnt3A driven dedifferentiation
of adipocytes decreases the medium and long forms of Col18a1 (Aikio
et al., 2014). In contrast, SFRP5 is normally induced during differentia-
tion to attenuate Wnt signaling (Christodoulides et al., 2009) and in-
creased during diet-induced obesity (Koza et al., 2006; Lagathu et al.,
2009; Mori et al., 2012; Okada et al., 2009). Positive Wnt/β-cateninsignaling inhibits adipogenesis and Sfrp5 is strongly induced during ad-
ipocyte differentiation to counteract it (Christodoulides et al., 2009).
Consequently, Sfrp5-deﬁcient mice are resistant to obesity (Mori et al.,
2012). Interestingly, reduced hepatic SFRP5 (mRNA and protein) ex-
pression in morbidly obese women is associated with fatty liver disease
(Gutierrez-Vidal et al., 2015). Overall, the difference in Sfrp5 induction
in Tg-FABP4-RORα4 tg/+mice supports the ﬁndings of reducedweight
gain associated with speciﬁc reduction of SAT fat deposition/expansion
in HFD-fed Tg-FABP4-RORα4 tg/+ mice, and further suggests that the
ability to expand the adipose tissue may be altered in these mice.
Conversely, ECM accumulation in the liver is a hallmark of hepatic
ﬁbrosis and is associated with hepatic stellate cell activation due to
inﬂammatory signaling (Bataller and Brenner, 2005). ECM
reprogramming is necessary for adipose growth and expansion on
energy dense diets, and ﬁbrosis in fat tissue is associated with obesi-
ty in humans. In children, the presence of collagen in fat is associated
with adipocyte size, body mass index and M2 phenotype macro-
phages, providing further evidence of the association between ECM
remodeling and innate immunity (Tam et al., 2012). Interestingly,
loss of collagen 18 (signiﬁcantly down-regulated by ~2–3-fold in
Tg-FABP4-RORα4 SAT) results in reduced adiposity, ectopic deposi-
tion of fat in the liver and hypertriglyceridemia (Aikio et al., 2014).
The phenotype was attributed to reduce fat storage capacity as a re-
sult of perturbations in adipocyte development. Interestingly, subcu-
taneous lipodystrophy, liver steatosis and glucose intolerance are
observed in humans with PPAR γ mutations Clearly both are NR de-
pendent, and the metabolic phenotypes have clear parallels (Savage
et al., 2003).
Another interesting feature revealed by the RNA-seq analysis sug-
gests increased T-cell involvement/recruitment in the SAT of Tg-
FABP4-RORα4 mice. While RORα is known to regulate inﬂammation
and inﬂuence the development of speciﬁc lymphocyte populations, for
example T helper 17 cells and group 2 innate-like lymphocytes (Halim
et al., 2012; Mjosberg et al., 2012), the biological signiﬁcance of the in-
creased lymphocyte inﬁltrate in this mouse model and its relation to
the phenotypes remains to be elucidated.
Overall, our collective data suggests that RORα overexpression in
the SAT inhibits adipose plasticity, reducing fat deposition and expan-
sion in the tissue, in addition to a shift in lipid homeostasis toward in-
creased lipolysis and mobilization to secondary organs. This
potentially perpetuates increased inﬂammatory signaling and hepatic
stellate cell activation in the liver, activating the ﬁbrotic program. The
evident adverse effects on the liver are possibly a compensatory mech-
anism for adipose dysfunction. Pathway analysis of the liver provides
support for this hypothesis, predicting inhibition of PPARα signaling
and activation of IL-6 signaling.
In humans, there is a positive correlation between greater amounts
of lower-body (gluteo-femoral in particular) SAT depots and protection
against glucose intolerance and insulin resistance, dyslipidemia and
atherosclerosis (reviewed in Manolopoulos et al., 2010). In this context,
our data is in linewith the view that subcutaneous fat serves as a protec-
tive metabolic sink for excess energy and loss of this depot/protection
leads to ectopic fat accumulation and impaired glucose clearance. This
severely hinders normal tissue function and perpetuates considerable
amounts of stress in these organs. Moreover, recent studies report met-
abolic beneﬁts acquired after SAT transplantation into the intra-abdom-
inal cavity in mice, effectively conferring protection against HFD-
induced glucose intolerance and hepatic lipid loading (Hocking et al.,
2015; Konrad et al., 2007; Tran et al., 2008). For example, mice im-
planted intra-abdominallywith SAT, but not epididymal visceral tissues,
were protected against HFD-induced glucose intolerance. These mice
were also protected against hepatic triacylglycerol accumulation and in-
ﬂammation after HFD. However, the underlying mechanism remains
obscure as there were no differences in weight gain, glucose uptake by
other tissues (including the skeletal muscle), or plasma adipokine con-
centrations (Hocking et al., 2015).
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and transplantation of SAT into intra-abdominal cavity, it is clear
that maintenance (or even supplementation) of SAT integrity offers
protection against glucose intolerance and lipid imbalance during
metabolic disease. Failure to sustain or expand adequate subcutane-
ous fat storage adversely impacts glucose tolerance and contributes
to ectopic fat accumulation in non-adipose organs such as the liver,
increasing susceptibility to inﬂammatory stress and cancer (Gentile
et al., 2015; Hocking et al., 2015; Wree et al., 2011). The pathology
presented thus far in the Tg-FABP4-RORα4 transgenic mouse
model is reminiscent of metabolic dysfunction, such as those of
childhood and adolescent obesity. Obese youths typically present
with (i) decreased subcutaneous adiposity, (ii) adipose tissue dys-
function accompanied with macrophage, dendritic cells and T-cells
recruitment and pro-inﬂammatory signaling, (iii) increased hepatic
lipid deposition/steatosis and muscle lipid deposition, and (iv) im-
paired glucose tolerance and insulin sensitivity (Corgosinho et al.,
2012; Aguilar et al., 2013; Rigamonti et al., 2013; Burgert et al.,
2006; Santoro et al., 2013).
Finally, in the context of this adipose speciﬁc FABP4 transgenic (over
expression) mouse model phenotype, it is essential to discuss the ca-
veats of this animal model. In the last ﬁve years several reviews have
highlighted the advantages and disadvantages of the different pro-
moters (for example FABP4 vs. adiponectin) for adipose speciﬁc gain
and loss of function studies including the following: (i) physiological
implications of leaky expression in non-adipose tissues and over ex-
pression and (ii) ectopic gene position and copy number (Wang et al.,
2010; Kang et al., 2014; Jeffery et al., 2014; Wang et al., 2014; Lee et
al., 2013). Recently it has been demonstrated that the FABP4 and
adiponectin Cre produced very similar phenotypes in side by side com-
parisons (Kim et al., 2016). However, these qualiﬁcations we discussed
above need to be considered in the interpretation of any transgenic over
expression model.
In conclusion, this animalmodel study suggests that the NR, RORα4,
has a critical regulatory role in the phenotype associatedwith decreased
subcutaneous fat deposition, fatty liver and impaired glucose tolerance.
Thus, establishing a role for RORα in these processes will potentially
allow us to pharmacological exploit its regulation for treatment of
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